328 related articles for article (PubMed ID: 26397159)
1. Expression Patterns of the Wnt Pathway Inhibitors Dickkopf3 and Secreted Frizzled-Related Proteins 1 and 4 in Endometrial Endometrioid Adenocarcinoma: An NRG Oncology/Gynecologic Oncology Group Study.
Eskander RN; Ali S; Dellinger T; Lankes HA; Randall LM; Ramirez NC; Monk BJ; Walker JL; Eisenhauer E; Hoang BH
Int J Gynecol Cancer; 2016 Jan; 26(1):125-32. PubMed ID: 26397159
[TBL] [Abstract][Full Text] [Related]
2. Prospective phase II trial of levonorgestrel intrauterine device: nonsurgical approach for complex atypical hyperplasia and early-stage endometrial cancer.
Westin SN; Fellman B; Sun CC; Broaddus RR; Woodall ML; Pal N; Urbauer DL; Ramondetta LM; Schmeler KM; Soliman PT; Fleming ND; Burzawa JK; Nick AM; Milbourne AM; Yuan Y; Lu KH; Bodurka DC; Coleman RL; Yates MS
Am J Obstet Gynecol; 2021 Feb; 224(2):191.e1-191.e15. PubMed ID: 32805208
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of enhance of Zeste homolog 2 (EZH2) in endometrial carcinoma: An NRG Oncology/Gynecologic Oncology Group Study.
Krill L; Deng W; Eskander R; Mutch D; Zweizig S; Hoang B; Ioffe O; Randall L; Lankes H; Miller DS; Birrer M
Gynecol Oncol; 2020 Feb; 156(2):423-429. PubMed ID: 31843273
[TBL] [Abstract][Full Text] [Related]
4. Expression of the Wnt antagonist Dickkopf-3 is associated with prognostic clinicopathologic characteristics and impairs proliferation and invasion in endometrial cancer.
Dellinger TH; Planutis K; Jandial DD; Eskander RN; Martinez ME; Zi X; Monk BJ; Holcombe RF
Gynecol Oncol; 2012 Aug; 126(2):259-67. PubMed ID: 22555103
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of enhancer of zeste homolog 2 (EZH2) expression is associated with decreased tumor cell proliferation, migration, and invasion in endometrial cancer cell lines.
Eskander RN; Ji T; Huynh B; Wardeh R; Randall LM; Hoang B
Int J Gynecol Cancer; 2013 Jul; 23(6):997-1005. PubMed ID: 23792601
[TBL] [Abstract][Full Text] [Related]
6. Impact of hormonal biomarkers on response to hormonal therapy in advanced and recurrent endometrial cancer.
van Weelden WJ; Lalisang RI; Bulten J; Lindemann K; van Beekhuizen HJ; Trum H; Boll D; Werner HMJ; van Lonkhuijzen LRCW; Yigit R; Forsse D; Witteveen PO; Galaal K; van Ginkel A; Bignotti E; Weinberger V; Sweegers S; Kroep JR; Cabrera S; Snijders MPLM; Inda MA; Eriksson AGZ; ; Krakstad C; Romano A; van de Stolpe A; Pijnenborg JMA
Am J Obstet Gynecol; 2021 Oct; 225(4):407.e1-407.e16. PubMed ID: 34019887
[TBL] [Abstract][Full Text] [Related]
7. Loss of SFRP1 Expression Is Associated with Poor Prognosis in Hepatocellular Carcinoma.
Davaadorj M; Imura S; Saito YU; Morine Y; Ikemoto T; Yamada S; Takasu C; Hiroki T; Yoshikawa M; Shimada M
Anticancer Res; 2016 Feb; 36(2):659-64. PubMed ID: 26851021
[TBL] [Abstract][Full Text] [Related]
8. SFRP4 was overexpressed in colorectal carcinoma.
Huang D; Yu B; Deng Y; Sheng W; Peng Z; Qin W; Du X
J Cancer Res Clin Oncol; 2010 Mar; 136(3):395-401. PubMed ID: 19730886
[TBL] [Abstract][Full Text] [Related]
9. MiR-328 promotes glioma cell invasion via SFRP1-dependent Wnt-signaling activation.
Delic S; Lottmann N; Stelzl A; Liesenberg F; Wolter M; Götze S; Zapatka M; Shiio Y; Sabel MC; Felsberg J; Reifenberger G; Riemenschneider MJ
Neuro Oncol; 2014 Jan; 16(2):179-90. PubMed ID: 24305703
[TBL] [Abstract][Full Text] [Related]
10. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
Kong LY; Xue M; Zhang QC; Su CF
Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of secreted frizzled related protein 1 (SFRP1) predicts ampullary adenocarcinoma recurrence.
Cheng LC; Chao YJ; Overman MJ; Wang C-; Phan NN; Chen YL; Wang TW; Hsu HP; Shan YS; Lai MD
Sci Rep; 2020 Aug; 10(1):13255. PubMed ID: 32764696
[TBL] [Abstract][Full Text] [Related]
12. Expression pattern of DKK3, dickkopf WNT signaling pathway inhibitor 3, in the malignant progression of oral submucous fibrosis.
Zhou S; Zhu Y; Mashrah M; Zhang X; He Z; Yao Z; Zhang C; Guo F; Hu Y; Zhang C
Oncol Rep; 2017 Feb; 37(2):979-985. PubMed ID: 27959428
[TBL] [Abstract][Full Text] [Related]
13. Cyr61, a member of ccn (connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed) family, predicts survival of patients with endometrial cancer of endometrioid subtype.
Watari H; Xiong Y; Hassan MK; Sakuragi N
Gynecol Oncol; 2009 Jan; 112(1):229-34. PubMed ID: 19007976
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of Musashi-1 in endometrioid adenocarcinoma.
Ma L; Xu YL; Ding WJ; Shao HF; Teng YC
Int J Clin Exp Pathol; 2015; 8(5):4564-72. PubMed ID: 26191146
[TBL] [Abstract][Full Text] [Related]
15. Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus.
Zou H; Molina JR; Harrington JJ; Osborn NK; Klatt KK; Romero Y; Burgart LJ; Ahlquist DA
Int J Cancer; 2005 Sep; 116(4):584-91. PubMed ID: 15825175
[TBL] [Abstract][Full Text] [Related]
16. Molecular markers in recurrent stage I, grade 1 endometrioid endometrial cancers.
Moroney MR; Davies KD; Wilberger AC; Sheeder J; Post MD; Berning AA; Fisher C; Lefkowits C; Guntupalli SR; Behbakht K; Corr BR
Gynecol Oncol; 2019 Jun; 153(3):517-520. PubMed ID: 30910249
[TBL] [Abstract][Full Text] [Related]
17. S100A1 expression in ovarian and endometrial endometrioid carcinomas is a prognostic indicator of relapse-free survival.
DeRycke MS; Andersen JD; Harrington KM; Pambuccian SE; Kalloger SE; Boylan KL; Argenta PA; Skubitz AP
Am J Clin Pathol; 2009 Dec; 132(6):846-56. PubMed ID: 19926575
[TBL] [Abstract][Full Text] [Related]
18. Dysregulation of miR-181c expression influences recurrence of endometrial endometrioid adenocarcinoma by modulating NOTCH2 expression: An NRG Oncology/Gynecologic Oncology Group study.
Devor EJ; Miecznikowski J; Schickling BM; Gonzalez-Bosquet J; Lankes HA; Thaker P; Argenta PA; Pearl ML; Zweizig SL; Mannel RS; Brown A; Ramirez NC; Ioffe OB; Park KJ; Creasman WT; Birrer MJ; Mutch D; Leslie KK
Gynecol Oncol; 2017 Dec; 147(3):648-653. PubMed ID: 28969912
[TBL] [Abstract][Full Text] [Related]
19. Expression profiling of Wnt family of genes in normal and inflammatory bowel disease primary human intestinal myofibroblasts and normal human colonic crypt epithelial cells.
Hughes KR; Sablitzky F; Mahida YR
Inflamm Bowel Dis; 2011 Jan; 17(1):213-20. PubMed ID: 20848536
[TBL] [Abstract][Full Text] [Related]
20. Frequent promoter hypermethylation of Wnt pathway inhibitor genes in malignant astrocytic gliomas.
Götze S; Wolter M; Reifenberger G; Müller O; Sievers S
Int J Cancer; 2010 Jun; 126(11):2584-93. PubMed ID: 19847810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
